Efficacy and safety of bortezomib-containing induction chemotherapy for autologous stem cell transplantation-eligible Japanese multiple myeloma patients — A phase 2 multicenter trial —Daisuke KUDO,Kazuteru OHASHI,Takuya KOMENO,Yuichi NAKAMURA,Atsushi SHINAGAWA,Chikashi YOSHIDA,Yukitaka KATSURA,Ikuyo OTA,Kazuhiko KAKIHANA,Takeshi KOBAYASHI,Nobutaka KAWAI,Atsushi KATO,Ayako ARAI,Koh YAMAMOTO,Shigeo TOYOTA,Takashi KUMAGAI,Akira OHWADA, Toru MIKI,Mitsuo HORI,Yasushi OKOSHI,Hiroshi KOJIMA,Hisashi SAKAMAKIsemanticscholar（2015）引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
